Telehealth & Digital Health

The Detroit Pistons' groundbreaking deal with men's health platform Rugiet signals a new era in sports sponsorships, aiming to destigmatize men's wellness.

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Heart disease is the leading cause of premature death for Canadian women, yet it remains under-diagnosed and under-treated. A national movement is fighting back.

As dangerous health myths spread online, Canada's top OB-GYNs call misinformation a form of violence and launch new efforts to protect women's health.

A 15-year pharma alliance expands to Austria, bringing advanced relief to cancer patients suffering from chemotherapy's debilitating side effects.

Zoya Technologies unveils an autonomous AI clinic that operates without the cloud, promising to revolutionize healthcare in underserved regions worldwide.

A new German partnership aims to create variant-ready, room-temperature stable vaccines, moving beyond the limits of first-generation mRNA technology.

Median Technologies' eyonis® LCS gains landmark FDA clearance, promising to revolutionize early detection of the deadliest cancer with its AI-powered diagnostics.

A new subcutaneous autoinjector for Alzheimer's drug Leqembi could soon transform care for millions in China, moving treatment from hospital to home.

Johnson & Johnson unveils promising data for its next-gen AFib tech while reinforcing the safety of its current platform in a competitive market.

Hemex Health's portable Gazelle test gets FDA Breakthrough status, paving an accelerated path for a device already changing lives in over 40 countries.

Team USA partners with smart ring maker ŌURA, leveraging cutting-edge sleep and recovery data in the high-stakes quest for Olympic and Paralympic glory.

A vague error code on millions of TRUE METRIX glucose meters led to delayed care. The company is now issuing a critical warning to prevent further harm.

A national scholarship founded by a top neurosurgeon invests in students poised to solve healthcare’s biggest challenges, addressing critical workforce shortages.

Airrosti launches REACH, a new platform combining its proven myofascial release model with digital tools to tackle the $350B MSK problem.

Chinese brand CHANDO presented a decade of research at IMCAS, revealing a new epigenetic mechanism that could revolutionize brightening for Asian skin.

After winning a major award, OnMed's tech-enabled CareStation promises to revolutionize access to care. But can this hybrid model solve a national crisis?

Major brands and tech firm Rokt join the AHA's new initiative, using AI and the power of retail to fight the leading cause of death among women.

New clinical data reveals a minimally invasive spine implant significantly cuts pain, improves function, and reduces opioid use for SI joint dysfunction.

South Korean firm Neurophet wins its third FDA clearance for an AI tool that precisely tracks Alzheimer's therapy side effects, eyeing U.S. expansion.